Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.

Antimicrobial agents and chemotherapy - 1 Feb 2015

Yuan Lili, Wang Ying, Parker Daniel M, Gupta Bhavna, Yang Zhaoqing, Liu Huaie, Fan Qi, Cao Yaming, Xiao Yuping, Lee Ming-chieh, Zhou Guofa, Yan Guiyun, Baird J Kevin, Cui Liwang

Abstract excerpt

Chloroquine-primaquine (CQ-PQ) continues to be the frontline therapy for radical cure of Plasmodium vivax malaria. Emergence of CQ-resistant (CQR) P. vivax parasites requires a shift to artemisinin combination therapies (ACTs), which imposes a significant financial, logistical, and safety burden. Monitoring the therapeutic efficacy of CQ is thus important. Here, we evaluated the therapeutic efficacy of CQ-PQ for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Chloroquine

Share to Infant

Share to Malaria, Vivax

Share to Plasmodium vivax

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 25512415
DOI: 10.1128/AAC.04270-14
PMCID: PMC4335844

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.PMID 25512415Read ↗

Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.Semantic proximity Read ↗

Efficacy of Primaquine for the Radical Cure of Plasmodium vivax Malaria in Northeast Myanmar and the Impact of Cytochrome P450 2D6 Genotypes.Semantic proximity Read ↗

Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria.Semantic proximity Read ↗

Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016).Semantic proximity Read ↗

Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction.Semantic proximity Read ↗

In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.Semantic proximity Read ↗

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in NepalSemantic proximity Read ↗

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.Semantic proximity Read ↗

Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapse.Semantic proximity Read ↗

Genetic polymorphisms in genes associated with drug resistance in Plasmodium vivax parasites from northeastern Myanmar.Semantic proximity Read ↗

Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.Semantic proximity Read ↗

Estimating the probable cause of recurrence in Plasmodium vivax malaria: relapse, reinfection or recrudescence?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.